Studies related to COVID-19 Severity and Vitamin C

Effect Of High-Dose Zinc And Ascorbic Acid Supplementation Vs Usual Care On Symptom Length And Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A To Z Randomized Clinical Trial

Effect None
Values There were no significant differences in any outcomes between groups.
Trial Design Randomized trial
Trial Length 1-2 Weeks
Number of Subjects 214
Sex Both Genders
Notes for this study:
In this trial, people receiving outpatient care for COVID-19 received either 50 mg zinc gluconate, 8,000 mg vitamin C, both, or standard of care for 10 days. The primary outcome was the number of days required to reach a 50% reduction in symptoms such as fever, cough, shortness of breath, and fatigue. Other outcomes included days until symptoms completely resolved, hospitalization, death, and adverse effects.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.